The knowledge gained from understanding regulation of β cell development and function at the level of mRNA modifications could be immensely useful to optimize protocols to generate insulin-secreting β-like cells from human stem cells (Hrvatin et al., 2014), which is currently a promising method of replacing β cell loss in T1D. The gene discussed is INS; the disease is type 1 diabetes mellitus.